Vaxart Inc
NASDAQ:VXRT

Watchlist Manager
Vaxart Inc Logo
Vaxart Inc
NASDAQ:VXRT
Watchlist
Price: 0.7143 USD -1.09% Market Closed
Market Cap: 162.5m USD
Have any thoughts about
Vaxart Inc?
Write Note

Vaxart Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vaxart Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Vaxart Inc
NASDAQ:VXRT
Operating Expenses
-$89m
CAGR 3-Years
-18%
CAGR 5-Years
-31%
CAGR 10-Years
-12%
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$21.9B
CAGR 3-Years
-4%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$11.2B
CAGR 3-Years
-3%
CAGR 5-Years
4%
CAGR 10-Years
-8%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$13.4B
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.9B
CAGR 3-Years
-10%
CAGR 5-Years
-16%
CAGR 10-Years
-15%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.8B
CAGR 3-Years
-23%
CAGR 5-Years
-16%
CAGR 10-Years
-17%

See Also

What is Vaxart Inc's Operating Expenses?
Operating Expenses
-89m USD

Based on the financial report for Jun 30, 2024, Vaxart Inc's Operating Expenses amounts to -89m USD.

What is Vaxart Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-12%

Over the last year, the Operating Expenses growth was 15%. The average annual Operating Expenses growth rates for Vaxart Inc have been -18% over the past three years , -31% over the past five years , and -12% over the past ten years .

Back to Top